Journal profile · ONCOLOGY
Cancer Research Communications
ISSN 2767-9764 · American Association for Cancer Research · United States
Cancer Research Communications: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 2,550; median 141 days to acceptance (113 articles, last 24 months); 194 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Cancer Research Communications is published by American Association for Cancer Research and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Immunotherapy and Biomarkers, Immune cells in cancer and Cancer Genomics and Diagnostics, together about 26.8% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Cancer Research Communications is an open access peer-reviewed journal that encompasses the full spectrum of research on cancer. Launched in October 2021, the journal aims to accelerate the pace of discovery and stimulate innovation in cancer science and medicine by providing a venue for rapid open publication of hypotheses, methods, results, data resources, and new knowledge in all the varied disciplines of this quickly evolving field. Basic, translational, clinical, and population-level cancer research advances all fall within the scope of Cancer Research Communications. Articles report novel findings, provide support to previously published results, or present thought-provoking null results.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Elaine R. MardisPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Immunotherapy and BiomarkersMedicine14.4%
- Immune cells in cancerImmunology and Microbiology6.4%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology6.1%
- Cancer Cells and MetastasisMedicine5.7%
- CAR-T cell therapy researchMedicine5.7%
- Immunotherapy and Immune ResponsesImmunology and Microbiology5.3%
- Ferroptosis and cancer prognosisMedicine5%
- Lung Cancer Research StudiesMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 5.4LetPub ·
- SJR 2026-06
- 1.77LetPub ·
- SNIP 2026-06
- 0.8LetPub ·
- h-index
- 32OpenAlex ·
- i10-index
- 335OpenAlex ·
- 2-year mean citedness
- 4.68OpenAlex ·
- Self-citation rate
- 2.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 186LetPub ·
Articles by year OpenAlex count · 1,013 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 175 | 175 | 77 |
| 2025 | 194 | 194 | 623 |
| 2024 | 254 | 254 | 2,214 |
| 2023 | 227 | 227 | 2,864 |
| 2022 | 148 | 148 | 2,396 |
| 2021 | 15 | 15 | 263 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
141 daysMedian, submission to acceptance · P25–P75 97 days – 199 days
- Acceptance to online
- median 1 days (21 articles)
- Submission to online
- median 137 days
- Sample
- 113 articles with submission and acceptance dates (417 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 9 weeksLetPub ·
- Submission to publication (journal-reported)
- about 9 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,550 | Yes | CC BY | |
| OpenAlex | USD 2,550 | — | — | |
| LetPub | USD 2,550 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted1
- editorialThis page has a brief overview of the basic editorial process used by all the AACR journals to evaluate submitted manuscripts. Our goal is to select for publica…Length not stated
Policy excerpts from the journal's websiteLicense & copyright, Open access
- License & copyright Copyright Transfer and Article Reuse
We provide on this page an overview of the copyright and permissions policies of the AACR journals with guidance on published article reuse by authors and others.
Source ↗Publisher website ·- Open access Open Access, Free Access, and Article Archiving
In support of our commitment to providing wide access to research, authors may opt to publish their research as open access in one of the AACR "hybrid" journals or in AACR’s open access journal Cancer Research Communications (see section on Open Access for details). The AACR also assists authors in fulfilling major funder archiving Open Access mandates by depositing either the accepted author vers…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- American Association for Cancer Research
- Country or region
- United States
- Language
- English
- ISSN
- 2767-9764
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cancer Research Communications
What CAS zone is Cancer Research Communications in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cancer Research Communications is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Cancer Research Communications?
Based on the dates recorded on 113 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 141 days (interquartile range 97–199 days); authors report an average review time of about 9 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Cancer Research Communications?
According to LetPub and DOAJ records, Cancer Research Communications is indexed in ESCI, Scopus and DOAJ.
Is Cancer Research Communications open access, and what is the APC?
Cancer Research Communications is a fully open-access journal. APC about USD 2,550.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .